DVAX
$11.84
Revenue | $55.6Mn |
Net Profits | $0.22Mn |
Net Profit Margins | 0.39% |
Dynavax Technologies Corporation’s revenue fell -69.87% since last year same period to $55.6Mn in the Q4 2023. On a quarterly growth basis, Dynavax Technologies Corporation has generated -20.02% fall in its revenue since last 3-months.
Dynavax Technologies Corporation’s net profit fell -99.68% since last year same period to $0.22Mn in the Q4 2023. On a quarterly growth basis, Dynavax Technologies Corporation has generated -98.47% fall in its net profits since last 3-months.
Dynavax Technologies Corporation’s net profit margin fell -98.93% since last year same period to 0.39% in the Q4 2023. On a quarterly growth basis, Dynavax Technologies Corporation has generated -98.08% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.02 |
EPS Estimate Current Year | -0.02 |
Dynavax Technologies Corporation’s earning per share (EPS) estimates for the current quarter stand at -0.02 - a -100% fall from last quarter’s estimates.
Dynavax Technologies Corporation’s earning per share (EPS) estimates for the current year stand at -0.02.
Earning Per Share (EPS) | 0 |
Dynavax Technologies Corporation’s earning per share (EPS) fell -99.64% since last year same period to 0 in the Q4 2023. This indicates that the Dynavax Technologies Corporation has generated -99.64% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-11-02 | -0.01 | 0.1 | 1100% |
2024-02-22 | -0.01 | 0 | 116% |
2023-05-02 | -0.13 | -0.19 | -46.15% |
2023-08-03 | -0.09 | 0.03 | 133.33% |